サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1428320

臨床バイオマーカーの世界市場レポート 2024

Clinical Biomarkers Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
臨床バイオマーカーの世界市場レポート 2024
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

臨床バイオマーカーの市場規模は、今後数年間で急速に成長すると予想されています。 2028年には10.8%の年間複合成長率（CAGR）で461億1,000万米ドルに成長すると予想されます。予測期間で予想される成長は、コンパニオン診断の拡大、早期診断と疾病予防への重点の集中、高精度腫瘍学および神経変性疾患における応用の増加、感染症の蔓延に起因すると考えられます。予測期間の主な動向には、AIを活用したバイオマーカーの発見、機械学習の統合、マルチオミクスの統合、技術革新、主要企業間のパートナーシップが含まれます。

がん有病率の予想される増加は、将来の臨床バイオマーカー市場の成長を促進すると予想されます。がんとは、異常な細胞の制御されない増殖と分裂を特徴とする一連の疾患を指し、健康な身体組織に侵入して損傷を与える可能性があります。 臨床バイオマーカーは、がんを発症するリスクが高い個人の早期発見、リスク評価、モニタリングを促進することにより、がん予防において極めて重要な役割を果たします。たとえば、2021年 5月の時点で、国立医学図書館は、2040年に世界のがん患者数が2,840万人と予測されると報告しています。これは、2020年から47%の増加を反映しています。その結果、がんの高い罹患率は、臨床バイオマーカー市場の成長の触媒として機能します。

予想される高齢化人口の増加は、臨床バイオマーカー市場の成長に貢献する態勢が整っています。人口の高齢化は、社会における高齢者の割合が時間の経過とともに増加することを特徴とする人口動態の変化を意味します。世界の高齢化は加齢に関連した病気の有病率の上昇と関連しており、早期診断と病気の管理を強化するためのバイオマーカーが必要です。 2022年 10月の時点で、世界保健機関は、2030年までに世界の6人に1人が60歳以上になると予測しています。この期間中に、60歳以上の人口は2020年の10億人から14億人に増加すると予測されています。さらに、2050年までに、60歳以上の世界人口は倍増し、21億人に達すると予想されています。したがって、高齢化人口の増加は臨床バイオマーカー市場の重要な推進力です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 市場促進要因・市場抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 市場規模と成長実績、2018～2023年
  • 市場規模と成長予測、2023～2028年、2033年

第6章 市場セグメンテーション

  • 世界の臨床バイオマーカー市場、製品別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 製品
  • サービス
  • 世界の臨床バイオマーカー市場、技術別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 次世代シーケンス（NGS）
  • ポリメラーゼ連鎖反応（PCR）
  • 免疫組織化学（IHC）
  • 酵素免疫測定法（ELISA）
  • その他
  • 世界の臨床バイオマーカー市場、臨床領域別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • がんバイオマーカー
  • 心臓バイオマーカー
  • 神経系バイオマーカー
  • 感染症バイオマーカー
  • 免疫バイオマーカー
  • NIPT
  • その他
  • 世界の臨床バイオマーカー市場、用途別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 臨床診断
  • トランスレーショナルリサーチ（TR）
  • 世界の臨床バイオマーカー市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 受託研究機関（CRO）
  • 研究・学術研究所
  • バイオ医薬品・バイオテクノロジー企業
  • 診断センター
  • その他

第7章 地域および国の分析

  • 世界の臨床バイオマーカー市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界の臨床バイオマーカー市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 臨床バイオマーカー市場の競合情勢
  • 臨床バイオマーカー市場の企業プロファイル
    • Johnson and Johnson Services Inc.
    • F. Hoffmann-La Roche Ltd.
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
    • Danaher Corporation

第31章 その他の大手および革新的な企業

  • Merck KGaA
  • Becton Dickinson and Company
  • Eurofins Scientific
  • Agilent Technologies Inc.
  • Epigenomics AG
  • Grifols SA
  • Illumina Inc.
  • BioMerieux SA.
  • Charles River Laboratories International Inc.
  • PerkinElmer Inc.
  • Sartorius AG
  • Sysmex Corporation
  • Waters Corporation
  • Bio-Rad Laboratories Inc.
  • Bruker Corporation

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r14164

Clinical biomarkers are quantifiable biological traits that identify normal or diseased bodily functions, encompassing chemicals or physiological indices. They play a crucial role in improving patient care and advancing personalized medicine by providing valuable data about an individual's health condition, disease progression, and potential therapeutic targets.

The main components of clinical biomarkers are products and services. Products in the context of clinical biomarkers are items sold to meet customer needs or desires, whether physical or intangible, and they are utilized to aid in the diagnosis of diseases and conditions. Various technologies are employed in clinical biomarkers, including next-generation sequencing (NGS), polymerase chain reaction (PCR), immunohistochemistry (IHC), enzyme-linked immunosorbent assay (ELISA), and others. Clinical biomarkers cover a range of clinical areas, including cancer biomarkers, cardiac biomarkers, neurological biomarkers, infectious disease biomarkers, immunological biomarkers, non-invasive prenatal testing, and others. These biomarkers find applications in clinical diagnostics and translational research and are utilized by various end-users such as contract research organizations (CROs), research and academic laboratories, biopharmaceutical and biotech companies, diagnostic centers, and others.

The clinical biomarkers market research report is one of a series of new reports from The Business Research Company that provides clinical biomarkers market statistics, including clinical biomarkers industry global market size, regional shares, competitors with a clinical biomarkers market share, detailed clinical biomarkers market segments, market trends, and opportunities, and any further data you may need to thrive in the clinical biomarkers industry. This clinical biomarkers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The clinical biomarkers market size has grown rapidly in recent years. It will grow from $27.66 billion in 2023 to $30.59 billion in 2024 at a compound annual growth rate (CAGR) of 10.6%. The expansion observed in the historical period can be attributed to the increased prevalence of chronic diseases, a focus on personalized medicine and targeted therapies, advancements in drug development and clinical trials, as well as regulatory support and funding.

The clinical biomarkers market size is expected to see rapid growth in the next few years. It will grow to $46.11 billion in 2028 at a compound annual growth rate (CAGR) of 10.8%. The anticipated growth in the forecast period can be attributed to the expansion of companion diagnostics, a heightened focus on early diagnosis and disease prevention, increasing applications in precision oncology and neurodegenerative diseases, and the growing prevalence of infectious diseases. Major trends in the forecast period include AI-powered biomarker discovery, integration of machine learning, multi-omics integration, technological innovations, and partnerships among key players.

The anticipated increase in cancer prevalence is set to drive the growth of the clinical biomarker market in the future. Cancer refers to a group of disorders characterized by the uncontrolled growth and division of abnormal cells, posing the potential to invade and harm healthy bodily tissues. Clinical biomarkers play a pivotal role in cancer prevention by facilitating early detection, risk assessment, and monitoring of individuals at a high risk of developing cancer. For example, as of May 2021, the National Library of Medicine reports a projected global cancer burden of 28.4 million cases in 2040, reflecting a 47% increase from 2020. Consequently, the high prevalence of cancer serves as a catalyst for the growth of the clinical biomarker market.

The expected rise in the aging population is poised to contribute to the growth of the clinical biomarker market. An aging population signifies a demographic shift marked by an increasing proportion of elderly individuals within a society over time. The global aging population is linked to a heightened prevalence of age-related diseases, necessitating biomarkers to enhance early diagnosis and disease management. As of October 2022, the World Health Organization forecasts that by 2030, one out of every six individuals globally will be 60 years old or older. During this period, the population aged 60 and over is projected to rise from 1 billion in 2020 to 1.4 billion. Furthermore, by 2050, the global population of individuals aged 60 and older is expected to double, reaching 2.1 billion. Hence, the increasing aging population is a significant driver of the clinical biomarker market.

Technological advancements emerge as a prominent trend gaining traction in the clinical biomarker market, with major companies focusing on developing innovative technologies to maintain their market positions. For instance, in June 2023, Veravas Inc., a US-based manufacturer of medicinal products for enhancing laboratory medicine, introduced the VeraBIND (Biomarker Isolation and N-enrichment for Detection) technology. This technology offers a uniquely innovative and comprehensive approach to enhance the precision of biomarker identification, reducing the likelihood of false positive or negative results across various sample types. The implementation of VeraBIND in clinical laboratories can improve diagnostic procedures, aiding in early disease detection and enabling prompt, focused interventions. Additionally, VeraBIND facilitates quicker assay creation, ensuring precision and consistency in studies, clinical trials, and diagnostic screenings.

Major companies in the clinical biomarker market are directing their efforts toward developing innovative solutions, including biomarker blood tests. Biomarker blood tests involve assessing specific biomolecules present in the blood to provide information about various physiological or pathological conditions in the body. For instance, in July 2023, Quanterix Corporation, a US-based ultra-sensitive digital immunoassay platform developing company, introduced the 'LucentAD.' This biomarker blood test is designed to assist in assessing patients exhibiting cognitive symptoms consistent with the initial indications of Alzheimer's disease (AD). LucentAD utilizes the extensively researched Simoa p-Tau 181 assay, which has undergone thorough examination in both large longitudinal and cross-sectional cohorts.

In June 2021, NeoGenomics Laboratories, a US-based testing laboratory company, completed the acquisition of Inivata for $390 million. Through this acquisition, NeoGenomics Laboratories aims to bolster its competitive advantage and increase its market share in the clinical biomarker industry. Inivata is a UK-based biotechnology company offering liquid biopsies.

Major companies operating in the clinical biomarkers market report are Johnson and Johnson Services Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Merck KGaA, Becton Dickinson and Company, Eurofins Scientific, Agilent Technologies Inc., Epigenomics AG, Grifols S.A., Illumina Inc., BioMerieux SA., Charles River Laboratories International Inc., PerkinElmer Inc., Sartorius AG, Sysmex Corporation, Waters Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Qiagen N.V., Myriad Genetics Inc., Luminex Corporation, Veracyte Inc., Centogene N.V., NanoString Technologies Inc., Enzo Biochem Inc., Biocartis Group NV, Agendia Inc., Siemens Healthcare Private Limited.

North America was the largest region in the clinical biomakers market in 2023. The regions covered in the clinical biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the clinical biomarkers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The clinical biomarkers market consists of revenues earned by entities by providing services such as biomarker assay development, biomarker testing, and biomarker data analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The clinical biomarkers market also includes sales of immunoassay kits, point-of-care testing devices, and genetic testing panels. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Clinical Biomarkers Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on clinical biomarkers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for clinical biomarkers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The clinical biomarkers market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Offering: Product; Service
  • 2) By Technology: Next-Generation Sequencing (NGS); Polymerase Chain Reaction (PCR); Immunohistochemistry (IHC); Enzyme-Linked Immunosorbent Assay (ELISA); Other Technologies
  • 3) By Clinical Area: Cancer Biomarker; Cardiac Biomarker; Neurological Biomarker; Infectious Disease Biomarker; Immunological Biomarker; Non-Invasive Prenatal Testing; Other Clinical Areas
  • 4) By Application: Clinical Diagnostic; Translational Research
  • 5) By End User: Contract Research Organizations (CROs); Research and Academic Laboratories; Biopharmaceutical and Biotech Companies; Diagnostic Centers; Other End Users
  • Companies Mentioned: Johnson and Johnson Services Inc.; F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Clinical Biomarkers Market Characteristics

3. Clinical Biomarkers Market Trends And Strategies

4. Clinical Biomarkers Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Clinical Biomarkers Market Size and Growth

  • 5.1. Global Clinical Biomarkers Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Clinical Biomarkers Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Clinical Biomarkers Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Clinical Biomarkers Market Segmentation

  • 6.1. Global Clinical Biomarkers Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Product
  • Service
  • 6.2. Global Clinical Biomarkers Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Next-Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • Immunohistochemistry (IHC)
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Other Technologies
  • 6.3. Global Clinical Biomarkers Market, Segmentation By Clinical Area, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Cancer Biomarker
  • Cardiac Biomarker
  • Neurological Biomarker
  • Infectious Disease Biomarker
  • Immunological Biomarker
  • Non-Invasive Prenatal Testing
  • Other Clinical Areas
  • 6.4. Global Clinical Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Clinical Diagnostic
  • Translational Research
  • 6.5. Global Clinical Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Contract Research Organizations (CROs)
  • Research and Academic Laboratories
  • Biopharmaceutical and Biotech Companies
  • Diagnostic Centers
  • Other End Users

7. Clinical Biomarkers Market Regional And Country Analysis

  • 7.1. Global Clinical Biomarkers Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Clinical Biomarkers Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Clinical Biomarkers Market

  • 8.1. Asia-Pacific Clinical Biomarkers Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Clinical Biomarkers Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Clinical Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Clinical Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Clinical Biomarkers Market

  • 9.1. China Clinical Biomarkers Market Overview
  • 9.2. China Clinical Biomarkers Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Clinical Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Clinical Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Clinical Biomarkers Market

  • 10.1. India Clinical Biomarkers Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Clinical Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Clinical Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Clinical Biomarkers Market

  • 11.1. Japan Clinical Biomarkers Market Overview
  • 11.2. Japan Clinical Biomarkers Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Clinical Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Clinical Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Clinical Biomarkers Market

  • 12.1. Australia Clinical Biomarkers Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Clinical Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Clinical Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Clinical Biomarkers Market

  • 13.1. Indonesia Clinical Biomarkers Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Clinical Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Clinical Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Clinical Biomarkers Market

  • 14.1. South Korea Clinical Biomarkers Market Overview
  • 14.2. South Korea Clinical Biomarkers Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Clinical Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Clinical Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Clinical Biomarkers Market

  • 15.1. Western Europe Clinical Biomarkers Market Overview
  • 15.2. Western Europe Clinical Biomarkers Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Clinical Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Clinical Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Clinical Biomarkers Market

  • 16.1. UK Clinical Biomarkers Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Clinical Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Clinical Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Clinical Biomarkers Market

  • 17.1. Germany Clinical Biomarkers Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Clinical Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Clinical Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Clinical Biomarkers Market

  • 18.1. France Clinical Biomarkers Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Clinical Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Clinical Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Clinical Biomarkers Market

  • 19.1. Italy Clinical Biomarkers Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Clinical Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Clinical Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Clinical Biomarkers Market

  • 20.1. Spain Clinical Biomarkers Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Clinical Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.15. Spain Clinical Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Clinical Biomarkers Market

  • 21.1. Eastern Europe Clinical Biomarkers Market Overview
  • 21.2. Eastern Europe Clinical Biomarkers Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Clinical Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Clinical Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Clinical Biomarkers Market

  • 22.1. Russia Clinical Biomarkers Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Clinical Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Clinical Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Clinical Biomarkers Market

  • 23.1. North America Clinical Biomarkers Market Overview
  • 23.2. North America Clinical Biomarkers Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Clinical Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Clinical Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Clinical Biomarkers Market

  • 24.1. USA Clinical Biomarkers Market Overview
  • 24.2. USA Clinical Biomarkers Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Clinical Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Clinical Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Clinical Biomarkers Market

  • 25.1. Canada Clinical Biomarkers Market Overview
  • 25.2. Canada Clinical Biomarkers Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Clinical Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Clinical Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Clinical Biomarkers Market

  • 26.1. South America Clinical Biomarkers Market Overview
  • 26.2. South America Clinical Biomarkers Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Clinical Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Clinical Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Clinical Biomarkers Market

  • 27.1. Brazil Clinical Biomarkers Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Clinical Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Clinical Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Clinical Biomarkers Market

  • 28.1. Middle East Clinical Biomarkers Market Overview
  • 28.2. Middle East Clinical Biomarkers Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Clinical Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Clinical Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Clinical Biomarkers Market

  • 29.1. Africa Clinical Biomarkers Market Overview
  • 29.2. Africa Clinical Biomarkers Market, Segmentation By Offering, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Clinical Biomarkers Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Clinical Biomarkers Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Clinical Biomarkers Market Competitive Landscape And Company Profiles

  • 30.1. Clinical Biomarkers Market Competitive Landscape
  • 30.2. Clinical Biomarkers Market Company Profiles
    • 30.2.1. Johnson and Johnson Services Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. F. Hoffmann-La Roche Ltd.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Thermo Fisher Scientific Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Abbott Laboratories
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Danaher Corporation
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Clinical Biomarkers Market Other Major And Innovative Companies

  • 31.1. Merck KGaA
  • 31.2. Becton Dickinson and Company
  • 31.3. Eurofins Scientific
  • 31.4. Agilent Technologies Inc.
  • 31.5. Epigenomics AG
  • 31.6. Grifols S.A.
  • 31.7. Illumina Inc.
  • 31.8. BioMerieux SA.
  • 31.9. Charles River Laboratories International Inc.
  • 31.10. PerkinElmer Inc.
  • 31.11. Sartorius AG
  • 31.12. Sysmex Corporation
  • 31.13. Waters Corporation
  • 31.14. Bio-Rad Laboratories Inc.
  • 31.15. Bruker Corporation

32. Global Clinical Biomarkers Market Competitive Benchmarking

33. Global Clinical Biomarkers Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Clinical Biomarkers Market

35. Clinical Biomarkers Market Future Outlook and Potential Analysis

  • 35.1 Clinical Biomarkers Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Clinical Biomarkers Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Clinical Biomarkers Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer